Hepatitis B virus infection and interferon-inducible protein-10.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinica Terapeutica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.7417/CT.2015.1853PMID 26152631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmune thyroid disorders.

  2015cited by this paper
• Quantitative nucleic acid amplification methods for viral infections.

  2015cited by this paper
• Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection

  2015cited by this paper
• Molecular biology of hepatitis B virus infection.

  2015cited by this paper
• Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

  2015cited by this paper
• Hepatitis B virus large surface protein: function and fame.

  2015cited by this paper
• Genetic insights on host and hepatitis B virus in liver diseases.

  2014cited by this paper
• Chronic hepatitis B: Advances in treatment.

  2014cited by this paper
• Expression Profiles of Circulating Cytokines, Chemokines and Immune Cells in Patients With Hepatitis B Virus Infection

  2014cited by this paper
• Vertical transmission of hepatitis B virus: challenges and solutions

  2014cited by this paper
• Hepatitis B virus-induced hepatocellular carcinoma.

  2014cited by this paper
• Hepatitis B: prevalence and pathophysiology.

  2014cited by this paper
• Serum levels of interleukin‐22 and hepatitis B core‐related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B

  2014cited by this paper
• Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C.

  2014cited by this paper
• Prevention of hepatocellular carcinoma in patients with chronic hepatitis B.

  2014cited by this paper
• HBV-Associated Cryoglobulinemic Vasculitis: Remission after Antiviral Therapy with Entecavir

  2014cited by this paper
• Platelets promote liver immunopathology contributing to hepatitis B virus-mediated hepatocarcinogenesis.

  2014cited by this paper
• Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.

  2014cited by this paper
• A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection

  2014cited by this paper
• Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.

  2014cited by this paper
• Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.

  2014cited by this paper
• Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.

  2014cited by this paper
• Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China

  2014cited by this paper
• Immune response to hepatitis B vaccination in drug using populations: a systematic review and meta-regression analysis.

  2014cited by this paper
• Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications

  2014cited by this paper
• Adaptive response in hepatitis B virus infection

  2014cited by this paper
• Hepatitis B vaccination during pregnancy for preventing infant infection.

  2014cited by this paper
• Beyond the IFN-&ggr; horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis

  2014cited by this paper
• Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.

  2014cited by this paper
• Rapid downregulation of programmed death‐1 and interferon‐γ‐inducible protein‐10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B

  2013cited by this paper
• Corrigendum to “The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer” [Biochim. Biophys. Acta 1825 (2012) 117–129]

  2013cited by this paper
• CXCR3, a double-edged sword in tumor progression and angiogenesis.

  2013cited by this paper
• Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

  2013cited by this paper
• Chronic Hepatitis B in Children and Adolescents: Epidemiology and Management

  2013cited by this paper
• Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B.

  2013cited by this paper
• Expression of cytokines in mouse hepatitis B virus X gene-transfected model

  2013cited by this paper
• HCV-related autoimmune disorders in HCV chronic infection.

  2013cited by this paper
• Association of Interferon-gamma Induced Protein 10 Promoter Polymorphisms with the Disease Progression of Hepatitis B Virus Infection in Chinese Han Population

  2013cited by this paper
• Molecular Pathways: Hepatitis C Virus, CXCL10, and the Inflammatory Road to Liver Cancer

  2013cited by this paper
• The emerging role of CXC chemokines in epithelial ovarian cancer.

  2012cited by this paper
• Persistent Hepatitis B Viral Replication in a FVB/N Mouse Model: Impact of Host and Viral Factors

  2012cited by this paper
• Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection.

  2012cited by this paper
• Pattern recognition receptor responses in children with chronic hepatitis B virus infection.

  2012cited by this paper
• The chemokine superfamily revisited.

  2012cited by this paper
• Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

  2012cited by this paper
• IL28B and interferon‐gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV‐HCV‐coinfected patients

  2012cited by this paper
• IL‐22 and non‐ELR‐CXC chemokine expression in chronic hepatitis B virus‐infected liver

  2012cited by this paper
• Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain

  2011cited by this paper
• Hepatocellular carcinoma: the point of view of the hepatitis B virus.

  2011cited by this paper
• CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications

  2011cited by this paper
• CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis.

  2011cited by this paper
• Hepatitis B Surface Antigen (Hbsag) Decrease and Serum Interferon-Inducible Protein-10 Levels as Predictive Markers for Hbsag Loss during Treatment with Nucleoside/Nucleotide Analogues

  2011cited by this paper
• Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer.

  2011cited by this paper
• Identification of stage biomarkers for human African trypanosomiasis.

  2010cited by this paper
• A preliminary study on pro- and anti-inflammatory cytokine profiles in Plasmodium vivax malaria patients from central zone of India.

  2010cited by this paper
• Rheumatic manifestations of hepatitis

  2010cited by this paper
• Hepatitis B Virus Protein X-induced Expression of the CXC Chemokine IP-10 Is Mediated through Activation of NF-κB and Increases Migration of Leukocytes*

  2010cited by this paper
• Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV DNA level in patients with cirrhosis.

  2010cited by this paper
• A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B.

  2010cited by this paper
• Expression of TNF-alpha, TGF-beta, IP-10 and IL-10 mRNA in kidneys of hamsters infected with pathogenic Leptospira.

  2010cited by this paper
• Hepatitis B: The virus and disease

  2009cited by this paper
• Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.

  2009cited by this paper
• Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

  2009cited by this paper
• Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.

  2009cited by this paper
• Extrahepatic manifestations of chronic hepatitis C.

  2009cited by this paper
• Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cytokines and Chemokines in a Murine Model of Mycoplasma pneumoniae Pneumonia

  2009cited by this paper
• Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.

  2009cited by this paper
• Hepatitis B-related autoimmune manifestations.

  2009cited by this paper
• Endocrine manifestations of hepatitis C virus infection

  2009cited by this paper
• Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India

  2008cited by this paper
• CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.

  2008cited by this paper
• Expression of CXC chemokine IP-10 in patients with chronic hepatitis B.

  2008cited by this paper
• HCV infection: pathogenesis, clinical manifestations and therapy.

  2008cited by this paper
• High Values of CXCL10 Serum Levels in Mixed Cryoglobulinemia Associated With Hepatitis C Infection

  2008cited by this paper
• Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study

  2008cited by this paper
• Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.

  2008cited by this paper
• Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.

  2008cited by this paper
• Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers.

  2008cited by this paper
• Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells.

  2008cited by this paper
• Statements from the Taormina expert meeting on occult hepatitis B virus infection.

  2008cited by this paper
• Iodine-131 Given for Therapeutic Purposes Modulates Differently Interferon-γ-Inducible α-Chemokine CXCL10 Serum Levels in Patients with Active Graves’ Disease or Toxic Nodular Goiter

  2007cited by this paper
• B-cells and mixed cryoglobulinemia.

  2007cited by this paper
• Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection

  2007cited by this paper
• Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis.

  2007cited by this paper
• HCV-related autoimmune and neoplastic disorders: the HCV syndrome.

  2007cited by this paper
• Thyroid Cancer in HCV-Related Chronic Hepatitis Patients: A Case-Control Study

  2007cited by this paper
• Effects of CXCL10 on Dendritic Cell and CD4+ T-Cell Functions during Leishmania amazonensis Infection

  2007cited by this paper
• The multifaceted roles of chemokines in malignancy

  2006cited by this paper
• Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.

  2006cited by this paper
• High Levels of CXCL10 Are Produced by Intestinal Epithelial Cells in AIDS Patients with Active Cryptosporidiosis but Not after Reconstitution of Immunity

  2006cited by this paper
• High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis.

  2006cited by this paper
• Thyroid Disorders in Chronic Hepatitis C Virus Infection

  2006cited by this paper
• Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.

  2006cited by this paper
• Hepatitis C virus infection: evidence for an association with type 2 diabetes.

  2005cited by this paper
• Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88.

  2005cited by this paper
• The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma.

  2005cited by this paper
• Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans.

  2005cited by this paper
• Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis.

  2005cited by this paper
• Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia.

  2004cited by this paper
• Extrahepatic manifestations of chronic hepatitis B.

  2004cited by this paper

• Interferon‐γ+ Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization

  2024cites this paper
• IP10 and Anti-HBc can Predict Virological Relapse and HBsAg Loss in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Discontinuation

  2023cites this paper
• Overt Acute Hepatitis B Deteriorates in Females: Destructive Immunity With an Exaggerated Interleukin-17 Pathway

  2021cites this paper
• Delivery of Toll-Like Receptor 3 Ligand Poly(I:C) to the Liver by Calcium Phosphate Nanoparticles Conjugated with an F4/80 Antibody Exerts an Anti-Hepatitis B Virus Effect in a Mouse Model.

  2021cites this paper
• Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway

  2020cites this paper
• The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection

  2019cites this paper
• HBV antigen and DNA loss from mouse serum is associated with novel vaccine‐induced HBV surface antigen‐specific cell‐mediated immunity and cytokine production

  2019cites this paper
• Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China

  2018cites this paper
• Impact of hepatitis B vaccination on HBsAg kinetics , interferon-inducible protein 10 level and recurrence of viremia

  2017cites this paper
• Impact of hepatitis B vaccination on HBsAg kinetics, interferon‐inducible protein 10 level and recurrence of viremia

  2017cites this paper
• Interferon-γ-induced protein 10 in Lyme disease.

  2017cites this paper
• Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment

  2016cites this paper